Peptone Market to Reach $240.5 million, Globally, by 2035 at 4.2% CAGR

According to the report, the "peptone market" was valued at $135.2 million in 2019, and is estimated to reach $240.5 million by 2035, growing at a CAGR of 4.2% from 2024 to 2035.

Request Sample of the Report on -

https://www.alliedmarketresearch.com/request-sample/3677

The growth of the peptone market is driven by its rising demand in biopharmaceutical production, microbial culture media, and diagnostics. In addition, increasing research in biotechnology and advancements in cell culture techniques further fuel market expansion.

The peptone market growth is primarily driven by the increasing demand for high-quality growth media in the biotechnology, pharmaceutical, and food industries. The rise in biopharmaceutical production, including vaccines and monoclonal antibodies, fuels the need for peptones as essential ingredients in microbial culture media. In addition, the growing demand for probiotics and nutritional supplements in the food and beverage industry supports market growth. Advancements in microbiology research and the expansion of the healthcare sector also contribute to the growing adoption of peptones in laboratory and clinical settings.

Connect to our Analyst -

https://www.alliedmarketresearch.com/connect-to-analyst/3677

The animal peptone segment held the largest market share in 2023.

By source of peptone, the animal peptone segment held the largest market share in 2023, accounting for more than half of the peptone revenue. This is attributed to the increased production of biologics, vaccines, and monoclonal antibodies that require high-quality culture media enriched with animal peptones. Also, a further surge in the number of chronic diseases boosts drug discovery, and vaccine development, which increases the adoption of animal peptone.

However, the mixed peptone segment is expected to witness the fastest CAGR of 5.2% from 2024 to 2035 owing to the growing demand for advanced biopharmaceutical products, especially vaccines and biologics, is a major factor fueling the growth of the mixed peptone market. In addition, the rising prevalence of chronic diseases and the growing emphasis on personalized medicine are also expected to boost the demand for mixed peptones, as they are essential for optimizing cell culture conditions in the development of customized products.

The pharmaceutical & biotech industry segment held the largest market share in 2023.

By end user, the pharmaceutical & biotech industry segment held the largest market share in 2023, accounting for more than two-fifths of the peptone market revenue and is expected to witness the fastest CAGR of 5.1% from 2024 to 2035. This is attributed to the increasing demand for biopharmaceutical products, such as vaccines, monoclonal antibodies, and therapeutic proteins, which significantly boosts the need for peptones as essential growth media components for cell culture. Moreover, increasing investments and funding in the biopharmaceutical and biotechnology industries as well as increase in launches of new peptone products further drive the growth of the market.

The cell culture segment held the largest market share in 2023.

By application, the cell culture segment held the largest market share in 2023, accounting for two-fifths of the peptone revenue and is expected to witness the fastest CAGR of 5.6% from 2024 to 2035 owing to the increasing adoption of cell culture techniques in drug discovery, tissue engineering, and vaccine production. In addition, the rise in research and development activities, especially in the field of personalized medicine, is further propelling the need for high-quality peptones.

North America to maintain its dominance by 2035

By Region, North America held the largest market share in terms of revenue in 2023, accounting for more than two-fifths of the peptone revenue and is expected to dominate the market during the forecast period. This is attributed to increase in the well-developed healthcare industry, and presence of leading manufacturers in the region.

However, the Asia-Pacific region is expected to witness the fastest CAGR of 4.7% from 2024 to 2035. This is attributed to expansion of the biotechnology and pharmaceutical sectors, increasing research activities in the fields of microbiology, molecular biology, and genetic engineering.

For Purchase Related Queries/Inquiry -

https://www.alliedmarketresearch.com/purchase-enquiry/3677

Leading Market Players: -

Thermo Fisher Scientific Inc
Solabia Group
Kerry Inc
Nu-Tek Biosciences
Becton Dickinson and Company
Himedia Laboratories
Liofilchem S.R.L
Neogen Corporation
Merck KGaA
Titan Biotech Ltd.

Trending Reports in Healthcare Industry:

Amniotic Product Market https://www.alliedmarketresearch.com/amniotic-product-market-A216556

Allergy Immunotherapy Market https://www.alliedmarketresearch.com/allergy-immunotherapy-market-A10241

Behavioral Rehabilitation Market https://www.alliedmarketresearch.com/degenerative-disc-disease-treatment-market-A269439

Curved Temperature Monitor Patch Market https://www.alliedmarketresearch.com/compact-c-arm-market-A323990

David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

This release was published on openPR.